<DOC>
	<DOCNO>NCT01503008</DOCNO>
	<brief_summary>The study test whether Proteus Sustained Behavior Change ( SBC ) System help Type 2 diabetic feel able perform self-care activity , feel less distressed diabetes , reduce mean fast blood glucose level . The SBC system use ingestible wearable sense device mobile phone reinforce positive behavior around medication usage , exercise rest .</brief_summary>
	<brief_title>Proteus Sustained Behavior Change Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>2,4-thiazolidinedione</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Glycoside Hydrolase Inhibitors</mesh_term>
	<criteria>Selfreported diagnosis Type 2 Diabetes Mellitus within past 212 month Hemoglobin A1c ≥7.5 ≤11 , obtain pointofcare HbA1c diagnostic device enrollment visit Selfreported current use metformin Type 2 diabetes Male female ≥ 18 Outpatient Selfreported capacity perform `` moderate '' exercise , specify 2010 joint American College Sports Medicine/American Diabetes Association guideline Designation one caregiver involve study entire duration . A caregiver relative , friend , train untrained hired individual . Selfreported mobile phone reception home and/or work Willingness adhere study procedure , include troubleshoot Raisin System thirdparty need . The third party blind personal subject identifier . Capacity read speak English proficiently , judge investigator screen interview Capacity understand instruction study , judge investigator screen interview Selfreported treatment metformin le 2 month time screen Selfreported adverse reaction metformin ( e.g. , ongoing nausea , vomit , bloating , diarrhea ) concomitant medication administer time screen Selfreported use injectable hypoglycemic agent , insulin , exenatide , liraglutide pramlintide Physical medical condition could prevent safe participation moderate level physical activity , survey Physical Activity Readiness Questionnaire ( PARQ ) interpret investigator Inability use mobile phone ( e.g. , find icon open read SMS ) , inability operate approve glucometer provide use study Selfreported current ( i.e. , last 12 month ) alcohol drug abuse ( include , limited , use marijuana ) Positive urine pregnancy test woman Women child bear potential use medically accept mean contraception . Accepted mean contraception include oral contraceptive implant , condom , diaphragm , spermicide , intrauterine device , tubal ligation , partner vasectomy Selfreported history myocardial infarction within past 60 day Selfreported history cerebral vascular accident within past 60 day Selfreported history skin sensitivity adhesive medical tape metal Selfreported history acute chronic dermatitis , exclude atopic dermatitis Selfreported allergy could preclude safe participation study Current participation another clinical study , participation clinical study past 30 day investigational device drug use Any condition , investigator 's opinion , would preclude subject 's able meet protocol requirement , would compromise subject 's safety participation study Presence cognitive impairment , judge investigator screen interview Inability provide inform consent reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>